Cordycepin: Phase I/II started

OncoVista began an open-label, U.S. Phase I/II trial to evaluate cordycepin plus pentostatin on days 1, 2 and 3 of a 21-day cycle in about 44 patients. The company acquired cordycepin, which has Orpha...